期刊文献+

单纯疱疹病毒2型DNA提取及ICP10启动子基因获得和纯化 被引量:1

Isolation of DNA from HSV-2 and Purification of ICP10 Promoter Gene
下载PDF
导出
摘要 目的用单纯疱疹病毒2型DNA,扩增并纯化得到ICP10启动子基因。方法培养vero细胞并接种HSV-2,获得大量HSV-2。用酚:氯仿提取病毒DNA,用PCR方法获得病毒ICP10启动子基因,并用UNIQ-10柱试剂盒纯化PCR产物。结果接种病毒的vero细胞出现病变,病变为“”,收集细胞,反复冻融3次,使细胞裂解,获得大量HSV-2。经PCR扩增获得641bp大小的目的基因片段。电泳显示片断大小符合。结论获得的ICP10启动子基因,经过测序正确后,可以和其他基因连接,用于进一步研究。 Objective Amplification, purification of ICP10 promoter gene. Methods DNA of HSV- 2 is isolated from culture vero cells.A pair of PCR primers were created from the ICP10 promoter gene of HSV-2 (Sal 5 strain) by DNA Star software and two restriction sites (Bgl Ⅱ and Hind Ⅲ ) were included as part of the primers, The gene fragment coding for ICP10 promoter was amplified by PCR. The PCR product was purified by PCR purification kit. Results A 641bp fragment was amplified by PCR. The gene fragment was proved to correct by agarose gel electrophoresis. Conclusion The gene fragment is used to ligate to vector after DNA sequencing.
作者 李雷生
出处 《济宁医学院学报》 2006年第4期1-3,共3页 Journal of Jining Medical University
关键词 人单纯疱疹病毒2型 启动子ICP10 PCR Human Herpes simplex virus type 2 ICP10 promoter Polymerase chain reaction
  • 相关文献

参考文献3

  • 1Lekstrom-Himes JA,Wang K,Pesnicak L,et al.The comparative biology of latent herpes simplex virus type 1 and type 2 infections:latency-associated transcript promoter activity and expression in vitro and in infected mice.J Neurovirol,1998,4(1):27
  • 2Wang YC,Kao CL,Liu WT,et al.A cell line that secretes inducibly a reporter protein for monitoring herpes simplex virus infection and drug susceptibility.J Med Virol,2002,68(4):59
  • 3Aurelian L,Kokuba H,Smith CC.Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).Vaccine,1999,17 (15 -16):1951

同被引文献12

  • 1杨秉芬,刘志敏.乙肝核心抗原作为免疫载体蛋白的研究进展[J].生物技术通讯,2005,16(2):180-182. 被引量:3
  • 2樊建勇,杨慧兰,关蕾,王颖,仕瑶慧.pVAX-Hsp70-HSV2gD DNA疫苗阳离子脂质体的制备[J].中国皮肤性病学杂志,2006,20(9):526-528. 被引量:1
  • 3徐金华,许炎,郑志忠,夏天,王健,梁俊,张臻,朱小华,朱乃硕.单纯疱疹病毒2型泛素化新型DNA疫苗构建[J].上海医学,2007,30(1):11-13. 被引量:3
  • 4Koelle D M.Vaccines for herpes simplex virus infections[J].Current Opinion in Investigational Drugs,2006,7(2):136-141.
  • 5Hoshino Y,Dalai S K,Wang K,et al.Comparative efficacy and immunogenicity of replication-defective,recombinant glycoprotein,and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs[J].J Virol,2005,79(1):410-418.
  • 6Fotouhi F,Soleimanjahi H,Roostaee M H,et al.Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs[J].Iranian Biomed J,2008,12(2):59-66.
  • 7Dudek T,Knipe D M.Replication-defective virus as vaccines and vaccine vectors[J].Virology,2006,344:230-239.
  • 8Milich D R,Melachln A,Thornoton G B,et al.The ncleocapsid of the hepatitis B virus is both a T-cell dependent and a T-cell independent antigen[J].Science,1986,234:1398.
  • 9Schodel F,Peterson D,Hughes J,et al.Hepatitis B virus core paticle as a vaccine carrier moiety[J].Int Rev Immunol,1994,11:153.
  • 10Koletzki D,Biel S S,Meisel H,et al.HBV core particle allow the insertion and surface exposure exposure of the entire potentially protective region of Puumala Hantavirus nucleocapsid protein[J].Biol Chem,1999,380:325-333.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部